Japan’s emerging role in bridging immunisation gap and supporting global health
Summary box The abrupt US suspension of funding to the US Agency for International Development and Gavi in 2025 threatens routine immunisation and child health programmes in low- and middle-income countries (LMICs), particularly in the Global South.
Authors
- Takuya Nakazawa (ORCID: https://orcid.org/0000-0003-4660-7177)
- Atsuo Katagiri
- Hideki Ohyama
- Hayase Hakariya (ORCID: https://orcid.org/0000-0002-9121-4551)
- Youichi Tanaka
- Yuka Iijima (ORCID: https://orcid.org/0009-0001-8064-5065)
Institutions
- Johns Hopkins University (US)
- Okayama University (JP)
- Yokohama University of Pharmacy (JP)
- Kyoto University (JP)
- Institute for Health Economics and Policy (JP)
- Zero Emissions Resource Organisation (NO)
- Institute of Science Tokyo (JP)
- University of Tübingen (DE)
Publication Details
- Journal
- BMJ Global Health
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1136/bmjgh-2025-020316
- Primary Topic
- Hepatitis Viruses Studies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eberhard Karls Universität Tübingen
- Japan Society for the Promotion of Science